PIP Insider Trading Activity and SEC Form 4 Filings
PIP insider trading summary
No open-market insider purchases or sales of Pharmathene, Inc (PIP) have been reported on SEC Form 4 in the past 12 months.
Latest PIP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 9, 2016 | Prescott Group Capital Management, L.L.C. | 10% Owner | Sell | $1.4M (436,324 @ $3.26) |
| Dec 9, 2016 | Phil Frohlich | 10% Owner | Sell | $1.4M (436,324 @ $3.26) |
| Dec 8, 2016 | Prescott Group Capital Management, L.L.C. | 10% Owner | Sell | $1.4M (440,479 @ $3.25) |
| Dec 8, 2016 | Phil Frohlich | 10% Owner | Sell | $1.4M (440,479 @ $3.25) |
| Dec 7, 2016 | Prescott Group Capital Management, L.L.C. | 10% Owner | Sell | $1.6M (477,829 @ $3.26) |
| Dec 7, 2016 | Phil Frohlich | 10% Owner | Sell | $1.6M (477,829 @ $3.26) |
| Apr 13, 2016 | Eric I Richman | Director | Sell | $200K (91,121 @ $2.20) |
| Apr 13, 2016 | Eric I Richman | Director | Sell | $330K (150,000 @ $2.20) |
| Apr 13, 2016 | Eric I Richman | Director | Sell | $165K (75,000 @ $2.20) |
| Apr 13, 2016 | Eric I Richman | Director | Sell | $29K (13,233 @ $2.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.